๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-06-08

A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder (NCT05624528)

A Double-Blind, Randomized, Placebo-Controlled Study of Tolcapone for OCD

๐Ÿ”ต Active, Not Recruiting Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: University of Chicago

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.

Who can join: Review the eligibility criteria below.

Location: University of Chicago Medical Center โ€” Chicago, Illinois

Age range: 18 Years to 65 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • University of Chicago Medical Center โ€” Chicago, Illinois

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—